0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Radiation Exposure During Intra-arterial Chemotherapy for Retinoblastoma—Reply

Carol L. Shields, MD; Rajakrishnan Vijayakrishnan, MD, PhD; Aparna Ramasubramanian, MD; Jacqueline Emrich, PhD; Pascal Jabbour, MD; Jerry A. Shields, MD
Arch Ophthalmol. 2012;130(3):403-405. doi:10.1001/archopthalmol.2012.173.
Text Size: A A A
Published online

Extract

In reply

We are disappointed by the misleading comments published by Gobin and colleagues on radiation exposure during IAC for retinoblastoma. Similar to other reports by their group, a consistent effort to underemphasize potential problems of IAC is evident. These problems include retinoblastoma recurrence, ischemic retinal and choroidal effects from chemotherapy and catheterization, and retinoblastoma metastasis, and now there is an effort to downplay the potential risk for radiation exposure. One concept we all agree on is that fluoroscopy exposes these children to radiation. Exactly how much radiation is dependent on several factors. The singular goal of our article1 was to explore the fluoroscopy risks in these young children, some with germline mutation. To our knowledge, this was not previously determined and was an important concern for those using IAC.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

March 1, 2012
Y. Pierre Gobin, MD; Leonard M. Rosenstein, PhD; Brian P. Marr, MD; Scott E. Brodie, MD, PhD; David H. Abramson, MD
Arch Ophthalmol. 2012;130(3):403-405. doi:10.1001/archopthalmol.2011.2717.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

32 Views
8 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();